Bottom line
IXJ vs TRUH: the short answer
IXJ (iShares Global Healthcare ETF) and TRUH (VanEck Healthcare TruSector ETF) share a meaningful slice of their top holdings — about 76% by weight.
But IXJ is far broader, holding 124 positions to 60 for TRUH, so beyond the top names it adds exposure TRUH doesn't have.
TRUH is cheaper at 0.1% vs 0.38% — a difference of $28 a year per $10,000 invested.
Updated Nov 19, 2026
IXJ vs TRUH side by side
| IXJ | TRUH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | VanEck |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.38% | 0.1% |
| Annual cost per $10k | $38 | $10 |
| 10-yr cost on $10k (prospectus) | $480 | — |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +14.9% | — |
| 5-yr return (annualized) | +6.4% | — |
| 10-yr return (annualized) | +8.2% | — |
| Best quarter | +13.6% | — |
| Worst quarter | −11.8% | — |
| Net assets (fund) | $3.8B | $833.1K |
| Number of holdings | 124 | 60 |
| Portfolio turnover | 2% | — |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
18 of IXJ's top 25 holdings also appear in TRUH's top 25.
| Holding | IXJ | TRUH |
|---|---|---|
| Eli Lilly And Company | 10.93% | 16.56% |
| Johnson & Johnson | 7.04% | 10.67% |
| Abbvie Inc. | 5.12% | 7.76% |
| Unitedhealth Group Incorporated | 4.40% | 6.59% |
| Merck & Co., Inc. | 4.12% | 5.54% |
| Amgen Inc. | 2.54% | 3.39% |
| Thermo Fisher Scientific Incorporated | 2.42% | 3.25% |
| Abbott Laboratories | 2.05% | 2.76% |
| Gilead Sciences, Inc. | 2.04% | 2.74% |
| Intuitive Surgical, Inc. | 1.83% | 2.48% |
| Pfizer Inc. | 1.78% | 2.40% |
| Cvs Health Corporation | 1.71% | 2.31% |
| Vertex Pharmaceuticals Incorporated | 1.64% | 2.21% |
| Danaher Corporation | 1.56% | 2.10% |
| Bristol-myers Squibb Company | 1.53% | 2.05% |
Source: SEC Form N-PORT
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
TRUH top 10
- Eli Lilly & Co — 16.56%
- Johnson & Johnson — 10.67%
- AbbVie Inc — 7.76%
- UnitedHealth Group Inc — 6.59%
- Merck & Co Inc — 5.54%
- Amgen Inc — 3.39%
- Thermo Fisher Scientific Inc — 3.25%
- Abbott Laboratories — 2.76%
- Gilead Sciences Inc — 2.74%
- Intuitive Surgical Inc — 2.48%
FAQ
What is the difference between IXJ and TRUH?
Which is cheaper, IXJ or TRUH?
Should I own both IXJ and TRUH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.